Neu5Gc
Neu5Gc is a sugar molecule that coats the cells of beef, pork and lamb, and one the human body can no longer make. Eaten in red meat, it gets built into our own tissues and draws an antibody response, and in engineered mice it speeds up tumours and artery plaque — a plausible part of why red meat behaves differently from poultry and fish, but one that rests on animal work, comes mostly from one research group and has never been tested in human outcome trials.
There is no standard test for it and no separate target to aim for. Keeping unprocessed red meat to about three portions a week, as advised in Red and processed meat, already limits it, and poultry and fish carry little.
A sugar humans lost
Sialic acids are sugars that decorate the surface of every vertebrate cell. Most mammals make two forms; the one humans cannot make is N-glycolylneuraminic acid, Neu5Gc for short. Around 2–3 million years ago a mutation switched off the gene that makes it, called CMAH, in our ancestors. We use a close relative instead, N-acetylneuraminic acid (Neu5Ac), which differs by a single oxygen atom.
Why the gene was lost is not settled. One leading explanation is escape from a malaria parasite that binds Neu5Gc: the ancestral chimpanzee parasite prefers it, and losing the sugar would have closed that door.[1] Others have been proposed, including reproductive compatibility and effects on brain development.[2]
Where you get it
Beef, pork and lamb are the main sources, and some dairy foods carry it too, goat's-milk cheese most. Poultry carries little, and so does fish, with one odd exception: fish roe and caviar were the richest foods measured.[3] Nobody has measured whether grass-fed beef carries less than grain-fed.
The case that it matters
When you eat red meat, some Neu5Gc is absorbed and built into your own cell membranes, particularly in the cells lining organs and blood vessels. The immune system recognises it as foreign and makes antibodies against it. The chronic low-grade inflammation this is thought to cause has been named xenosialitis. In a 2003 study, these antibodies reached up to 0.25% of circulating immunoglobulin G (the main class of antibody) in some people.[4]
Three lines of laboratory work build the case:
- Liver tumours. Mice engineered to lack the CMAH gene, immunised against Neu5Gc and then fed it, developed liver tumours much more often.[5]
- Artery plaque. In mice of the same kind that also carried antibodies against Neu5Gc, feeding it sped up plaque in the aorta.[6]
- Colorectal cells. Neu5Gc built into colorectal cells turns up the Wnt/β-catenin pathway, a growth signal in cancer, which offers a route to cancer progression that doesn't need the immune system at all.[7]
It is also offered as an explanation for the "chimpanzee paradox". Chimpanzees carry blood fats that would count as high-risk in a human, yet develop only mild atherosclerosis, without the rupture-prone plaques that cause human heart attacks. They are not spared heart disease: it is common in chimpanzees too, but runs through a different route, a diffuse scarring of the heart muscle that ends in an irregular heartbeat rather than a blocked artery.[8] Chimpanzees make Neu5Gc themselves and don't produce antibodies against the sugar in the meat they eat.
Why to hold it loosely
The biochemistry is well established; the step to human heart disease and cancer is not. It rests on animal models and antibody associations in people, not on outcome trials.
- The mouse model is disputed. Whether the plaque result in engineered mice says anything about human atherosclerosis was formally challenged in the same journal.[9] The original authors replied in the same issue, conceding in their title how hard it is to extrapolate from animal models while defending the finding.[10]
- The antibodies can't yet be measured reliably. Levels vary widely between people, and after fifty years there is still no standardised way to measure them. A 2024 review of 114 studies concluded that no reliable statement can yet be made about how common the antibodies are.[11]
- One group, with a commercial stake. Most of this research comes from a single group, two of whose members co-founded a company developing anti-Neu5Gc antibodies.[12]
What to do
- Follow the ordinary red-meat limit. About three portions of unprocessed red meat a week limits Neu5Gc along with everything else; there is no separate Neu5Gc target.
- Swapping some red meat for poultry or fish also swaps out most of the Neu5Gc. Fish roe and caviar are the exception.
- Don't treat grass-fed beef as lower in it. That has never been measured.
Further reading
- Samraj AN et al. A red meat-derived glycan promotes inflammation and cancer progression. PNAS 2015.[13]
- Kawanishi K et al. Human species-specific loss of CMP-N-acetylneuraminic acid hydroxylase enhances atherosclerosis via intrinsic and extrinsic mechanisms. PNAS 2019.[14]
- Soulillou JP et al. Can we extrapolate from a Cmah (-/-) Ldlr (-/-) mouse model a susceptibility for atherosclerosis in humans? PNAS 2020.[15]
- Hutton E et al. A systematic review reveals conflicting evidence for the prevalence of antibodies against the sialic acid 'xenoautoantigen' Neu5Gc in humans and the need for a standardised approach to quantification. Front Mol Biosci 2024.[16]
- Varki N et al. Heart disease is common in humans and chimpanzees, but is caused by different pathological processes. Evol Appl 2009.[17]
- Lopes AL et al. Dietary intake of the red meat-derived glycan Neu5Gc fuels colorectal cancer through up-regulation of Wnt signaling pathway. Cancer Lett 2025.[18]